Drug Distributors and Johnson & Johnson Reach $26 Billion Deal to End Opioid Suits

The agreement would allow funds to begin flowing from the companies to states and communities to pay for addiction and prevention services.

Source: NYT Health - July 22, 2021 Category: Consumer Health News Authors: Jan Hoffman Tags: Suits and Litigation (Civil) Opioids and Opiates Liability for Products Addiction (Psychology) Drugs (Pharmaceuticals) McKesson Corporation Cardinal Health Inc AmerisourceBergen Corp Johnson & your-feed-healthcare Source Type: news